Tibet Weixinkang Medicine Co., Ltd. (SHSE: 603676)
Health Care · Pharmaceuticals · CN
CN¥9.09
+2.71% today · -21.6% 1Y
Tibet Weixinkang Medicine Co., Ltd. (SHSE: 603676) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $585.87M and employs 763 people.
Over the last twelve months the share price has lost 21.6%, trading between 7.82 and 12.08.
Tweenvest scores Tibet Weixinkang Medicine Co., Ltd. across four factors: quality 77/100, value 58/100, growth 23/100, dividend 71/100. Its strongest factor is quality.
603676 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $585.87M
- Revenue (TTM)
- $166.92M
- P/E
- 20.26
- EPS
- 0.45
- Dividend yield
- 3.60%
- Beta (5Y)
- -0.08
- 52-week high
- CN¥12.08
- 52-week low
- CN¥7.82
- Avg volume (3M)
- —
- Shares outstanding
- 432.33M
- Employees
- 763
- Next earnings
- —
About Tibet Weixinkang Medicine Co., Ltd.
Tibet Weixinkang Medicine Co., Ltd., a pharmaceutical enterprise headquartered in Lhasa, China, is dedicated to the entire lifecycle of medicinal products within the country, encompassing their research and development, manufacturing, and sales. The company's diverse range of offerings includes specialized vitamins for parenteral nutrition, electrolyte solutions, intravenous iron preparations, antibiotic medications, and therapies designed for digestive system and liver conditions. Among its specific injectable products are multivitamins, potassium magnesium aspartate, iron sucrose, and potassium aspartate. Established in 2006, the firm operated under the name Weixinkang Medicine Youxian Gongsi until its rebranding to Tibet Weixinkang Medicine Co., Ltd. occurred in 2015.
- ISIN
- CNE100002QQ3
- Founded
- 2002
- Listed since
- Jul 21, 2017
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Zevra Therapeutics, Inc.NasdaqGS: ZVRA | $593.24M | $11.00 | +10.11% |
| Beijing Tong Ren Tang Chinese Medicine Company LimitedSEHK: 3613 | $593.03M | HK$5.56 | +1.74% |
| Hefei Lifeon Pharmaceutical Co., Ltd.SZSE: 003020 | $587.23M | CN¥17.26 | +1.59% |
| Shanghai Xiao Fang Pharmaceutical Co.,Ltd.SHSE: 603207 | $585.90M | CN¥24.46 | +0.87% |
| Jinhe Biotechnology CO., LTD.SZSE: 002688 | $585.82M | CN¥5.20 | +0.97% |
| Xiangxue Pharmaceutical Co.,Ltd.SZSE: 300147 | $581.64M | CN¥5.90 | +4.98% |
| Qianjiang Yongan Pharmaceutical Co., Ltd.SZSE: 002365 | $581.07M | CN¥13.48 | -2.53% |
| Middle East Pharmaceutical Industries CompanySASE: 4016 | $579.84M | SR62.20 | -3.12% |
Figures last refreshed Oct 4, 2026.